WTIM
DGX icon

Wilmington Trust Investment Management’s Quest Diagnostics DGX Stock Holding History

Wilmington Trust Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-4,100
Closed -$253K – 405
2013
Q3 		$253K Hold
4,100
– – 0.05% 319
2013
Q2 		$249K Buy
+4,100
New +$244K 0.05% 345

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wilmington Trust Investment Management's DGX Position: Q4 2013 in Review

Wilmington Trust Investment Management sold out of Quest Diagnostics (DGX) in Q4 2013, closing a stake of 4,100 shares — an estimated $253K sold.

Wilmington Trust Investment Management first reported a position in DGX in Q2 2013 and held it in 2 quarters. The position peaked at $253K in Q3 2013. 455 funds tracked by Wall St. Rank hold DGX as of Q4 2013.

  • Wilmington Trust Investment Management reported no remaining Quest Diagnostics position as of Q4 2013 after selling out during the quarter.
  • Wilmington Trust Investment Management sold 4,100 Quest Diagnostics shares in Q4 2013, an estimated $253K.
  • Wilmington Trust Investment Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 2 quarters.
  • Wilmington Trust Investment Management's Quest Diagnostics position peaked at $253K in Q3 2013.
  • 455 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2013.

Based on Wilmington Trust Investment Management's 13F filing for Q4 2013, filed 12 Feb 2014.